SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Comment Letter for NOVARTIS AG (NVS, NVSEF) (CIK 0001114448) (NVS) — Aug 29, 2013

NOVARTIS AG (NVS, NVSEF) (CIK 0001114448)
Date: Aug. 29, 2013 · CIK: 0001114448 · Accession: 0000000000-13-047742

AI Filing Summary & Sentiment

File numbers found in text: 001-15024

Date
January 23, 2013
Author
/s/ Joel Parker
Form
UPLOAD
Company
NOVARTIS AG (NVS, NVSEF) (CIK 0001114448)

Letter

August 29 , 2013 Via E-mail Mr. Jonathan Symonds Chief Financial Officer Novartis AG CH-4056 Basel Switzerland

Re: Novartis AG Form 20-F for Fiscal Year Ended December 31, 201 2 Filed January 23, 2013 File No. 001-15024

Dear Mr. Symonds :

We have completed our review of your filing. We remind you that our comments or changes to disclosure in response to our comments do not foreclose the Commission from taking any action with respect to the company or the filing and the company may not assert staff comments as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States. We urge all persons who are responsible for the accuracy and adequacy of the disclosure in the filing to be certain that the filing includes the information the Securities Exchange Act of 1934 and all applicable rules require.

Sincerely,
/s/ Joel Parker

Show Raw Text
August 29 , 2013

Via E-mail
Mr. Jonathan Symonds
Chief Financial  Officer
Novartis AG
CH-4056 Basel
Switzerland

Re: Novartis  AG
  Form 20-F for Fiscal Year Ended December 31, 201 2
  Filed January 23, 2013
File No. 001-15024

Dear  Mr. Symonds :

We have completed our review of your filing. We remind you that our comments
or changes to disclosure in response to our comments do not foreclose the Commission
from taking any action with respect to the company or the filing and the company may
not assert staff comments as a defense in any proceeding initiated by the Commission or
any person under the federal securities laws of the United States. We urge all persons
who are responsible for the accuracy and adequacy of the disclosure in the filing to be
certain that the filing includes the information the Securities Exchange Act of 1934 and
all applicable rules require.

Sincerely,

/s/ Joel Parker

Joel Parker
Accounting Branch Chief